Fenômeno de Will Rogers: O Que Todo Médico Deve Saber

Autor: JM Mota, PM Hoff

Publikováno v: Anais da Academia Nacional de Medicina. 192:167-173

William Penn Adair Rogers, ou simplesmente Will Rogers, foi um showman norte-americano que viveu entre 1879 e 1935. Nos dias de hoje, seu nome é pouco conhecido, mas Will Rogers foi muito famoso em seu tempo. Sua morte prematura após um trágico ac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2135c1f8d363683324edbc385ac877bd
https://doi.org/10.52130/27639878-aanm2021v192n3p167-173

Subcutaneous versus intravenous nivolumab for renal cell carcinoma.

Autor: Albiges L; Department of Oncology, Institut Gustave Roussy, Villejuif, France. Electronic address: Laurence.ALBIGES@gustaveroussy.fr., Bourlon MT; Urologic Oncology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Chacón M; Department of Oncology, Instituto Medico Especializado Alexander Fleming, Buenos Aires., Cutuli HJ; Uro-Oncology Research Unit, Hospital Sirio Libanês, Buenos Aires, Argentina., Chuken YAL; iCan Oncology Center, Monterrey, Mexico., Żurawski B; Department of Outpatient Chemotherapy, Prof. Franciszek Łukaszczyk Oncology Centre, Bydgoszcz, Poland., Mota JM; Instituto do Cancer do Estado de São Paulo, University of São Paulo, São Paulo, Brazil., Magri I; Centro Privado de RMI Rio Cuarto SA II, Rio Cuarto, Argentina., Burotto M; Medical Oncology Department, Centro de Investigación Clínica Bradford Hill, Santiago de Chile, Chile., Luz M; IOP Instituto de Oncologia do Paraná, Curitiba., de Menezes J; Department of Oncology, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil., Ruiz EPY; School of Medicine, Department of Oncology, Universidad de la Frontera, Temuco, Chile., Fu S; Auckland City Hospital, Auckland; Department of Oncology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Richardet M; Fundacion Richardet Longo, Instituto Oncologico de Cordoba, Cordoba, Argentina., Valderrama BP; Hospital Universitario Virgen del Rocio, Department of Medical Oncology, Sevilla, Spain., Maruzzo M; Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto, IOV-IRCCS, Padova., Bracarda S; Medical Oncology Department, Azienda Ospedaliera Santa Maria, Terni, Italy., Breckenridge M; Bristol Myers Squibb, Princeton., Vezina HE; Bristol Myers Squibb, Princeton., Rathod D; Bristol Myers Squibb, Princeton., Yu Z; Bristol Myers Squibb, Princeton., Zhao Y; Bristol Myers Squibb, Princeton., Dixon M; Bristol Myers Squibb, Princeton., Perumal D; Bristol Myers Squibb, Princeton., George S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Sep 15. Date of Electronic Publication: 2024 Sep 15.

Hydronephrosis as a Prognostic Factor in Primary Bladder Adenocarcinoma: Insights from a 15-Year Tertiary Center Experience.

Autor: Suartz CV; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil; University of Laval, Urology Department, Quebec, Canadá. Electronic address: caio.v_suartz@hotmail.com., Neto CV; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Botelho LAA; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Gallucci FP; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Flores HA; Division of Urology, University of Colorado Anschutz Medical Center, Aurora, Colorado, United States of America., Cardili L; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Mota JM; Urology Department, Genitourinary Medical Oncology Service, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Cordeiro MD; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Nahas WC; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil., Ribeiro-Filho LA; Division of Urology, Institute of Cancer of São Paulo, University of São Paulo, São Paulo, SP, Brazil.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Aug; Vol. 22 (4), pp. 102120. Date of Electronic Publication: 2024 May 14.

High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil.

Autor: Polho GB; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Cunha MT; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Coelho MHM; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Unit of Cell Therapy of Hematology/Cell therapy Department, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil., Almeida-Silva J; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Hidalgo Filho CM; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Xavier EM; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Unit of Cell Therapy of Hematology/Cell therapy Department, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil., Crusoe NS; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Atanazio MJ; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Unit of Cell Therapy of Hematology/Cell therapy Department, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil., de Vasconcellos VF; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Hospital Universitario Cassiano Antonio de Moraes, Universidade Federal do Espirito Santo, Espírito Santo, Brazil., Horita VN; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Freitas GF; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Muniz DQ; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Rocha V; Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31), Unit of Cell Therapy of Hematology/Cell therapy Department, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo (USP), Sao Paulo, SP, Brazil; Instituto DOr de Pesquisa e Ensino, Espírito Santo, Brazil., Mota JM; Genitourinary Medical Oncology Service, Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil; Instituto DOr de Pesquisa e Ensino, Espírito Santo, Brazil. Electronic address: jose.mota@hc.fm.usp.br.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Jun; Vol. 22 (3), pp. 102083. Date of Electronic Publication: 2024 Mar 24.

Robotic-assisted approaches to urachal carcinoma: A comprehensive systematic review of the safety and efficacy outcomes.

Autor: Suartz CV; Urology Department, Hôpital Européen Georges Pompidou, AP-HP. Centre Université Paris Cité Paris France.; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Martinez LM; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Brito PH; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Neto CV; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Cordeiro MD; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Botelho LAA; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Gallucci FP; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Mota JM; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Nahas WC; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil., Ribeiro-Filho LA; Division of Urology, Institute of Cancer of São Paulo University of São Paulo São Paulo Brazil.

Publikováno v: BJUI compass [BJUI Compass] 2024 Feb 01; Vol. 5 (3), pp. 327-333. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).